Zynerba Pharmaceuticals, Inc(NASDAQ:ZYNE) 
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe...
Website: http://www.zynerba.com
Founded: 2007
Full Time Employees: 28
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-04-14
P
O 0.40
H 0.42
L 0.38
C 0.41
V 105,359
10EMA 0.41
20EMA 0.41
60EMA 0.41
120EMA 0.41
250EMA 0.41